Business Context and Reporting Period
Company: ProQR Therapeutics N.V.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of March 2026
Date of Filing: March 25, 2026
This filing serves to distribute a press release announcing a scheduled virtual investor and analyst event. The registrant is a foreign private issuer based in Leiden, The Netherlands, filing under Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The primary update is the announcement of a future corporate event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: ProQR will host a virtual investor and analyst event on April 8, 2026.
- Focus: The event will highlight the company's pipeline.
- Regulatory Action: The information in this filing is incorporated by reference into the company's registration statements on Form F-3 (File Nos. 333-282419, 333-270943, 333-263166, and 333-285767).
Investor Verification Checklist
- Verify the date and agenda of the virtual investor event scheduled for April 8, 2026.
- Review the attached press release (Exhibit 99.1) for specific details on the pipeline updates to be discussed.
- Confirm the status of the referenced Form F-3 registration statements for potential capital raising activities.